Villalobos Violán V, González Cano B, Ángel Racionero Casero M, González-Mancebo E, Mohedano Vicente E, Trujillo Trujillo MJ, et al. Real-life experience after 3 months with tezepelumab before marketing approval. Allergol Immunopathol [Internet]. 2023 Mar. 1 [cited 2026 Apr. 22];52(2):80-2. Available from: https://www.all-imm.com/index.php/aei/article/view/1063